<p>/PRNewswire/ -- DJS 律师事务所提醒投资者，针对 Mereo BioPharma Group plc（“Mereo” 或 “公司”）（NASDAQ: MREO）提起的集体诉讼，因违反 1934 年证券交易法第§§10(b) 和 20(a) 及美国证券交易委员会制定的第 10b-5 条规则。</p>
<p>在列出的集体诉讼期间购买 MREO 股票的股东，鼓励与本事务所联系以讨论可能的首席原告任命。被任命为首席原告并不是参与任何赔偿的必要条件。</p>
<p>** 集体诉讼期间：**2023 年 6 月 5 日至 2025 年 12 月 26 日</p>
<p>** 截止日期：**2026 年 4 月 6 日</p>
<p><strong>案件详情：</strong> 根据投诉，公司向市场发布了虚假和误导性声明。Mereo 误导投资者关于其第三阶段 ORBIT 和 COSMIC 项目。这两个项目在对照组中未能达到其终点。基于这些事实，Mereo 在集体诉讼期间的公开声明是虚假且具有实质性误导性的。</p>
<p>如果您是遭受损失的股东，请联系我们以参与。</p>
<p><strong>为什么选择 DJS 律师事务所？</strong> DJS 律师事务所的主要关注点是通过平衡的咨询和积极的倡导来提高投资者回报。我们专注于证券集体诉讼、公司治理诉讼以及国内/国际并购评估。我们的客户是全球一些最大和最复杂的对冲基金和另类资产管理公司。我们客户的诉讼索赔是极其有价值的资产，值得尊重、关注和结果。</p>
<p>加入案件以追回您的损失。</p>
<p>本新闻稿在某些司法管辖区可能被视为律师广告，依据适用法律和伦理规则。</p>
<p><strong>联系方式：</strong></p>
<p>David J. Schwartz</p>
<p>DJS 律师事务所</p>
<p>274 White Plains Road, Suite 1</p>
<p>Eastchester, NY 10709</p>
<p>电话：914-206-9742</p>
<p>电子邮件：[email protected]</p>
<p>来源 DJS 律师事务所 LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMzEyJk5ld3NJdGVtSWQ9TEEwODY3MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAzMTIwNDE5UFJfTkVXU19VU1BSX19fX19MQTA4Njcx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMzEyJk5ld3NJdGVtSWQ9TEEwODY3MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAzMTIwNDE5UFJfTkVXU19VU1BSX19fX19MQTA4Njcx"/></p>

MREO

<p>Mereo BioPharma Group plc 正面临一起针对证券法违规的集体诉讼，具体指控其在关于第三阶段 ORBIT 和 COSMIC 项目的信息中误导投资者。诉讼声称该公司对这些项目的有效性做出了虚假陈述，而这些项目未能达到预期目标。2023 年 6 月 5 日至 2025 年 12 月 26 日期间购买股票的股东被鼓励联系 DJS Law Group 以申请潜在的首席原告。参与的截止日期为 2026 年 4 月 6 日</p>

<p>, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Mereo BioPharma Group plc (&#34;Mereo&#34; or &#34;the Company&#34;) (NASDAQ: MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.</p>
<div class="lb-trans"><p>/PRNewswire/ -- DJS 律师事务所提醒投资者，针对 Mereo BioPharma Group plc（“Mereo” 或 “公司”）（NASDAQ: MREO）提起的集体诉讼，因违反 1934 年证券交易法第§§10(b) 和 20(a) 及美国证券交易委员会制定的第 10b-5 条规则。</p>
</div><p>Shareholders who purchased shares of MREO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.</p>
<div class="lb-trans"><p>在列出的集体诉讼期间购买 MREO 股票的股东，鼓励与本事务所联系以讨论可能的首席原告任命。被任命为首席原告并不是参与任何赔偿的必要条件。</p>
</div><p><strong>CLASS PERIOD:</strong> June 5, 2023 to December 26, 2025</p>
<div class="lb-trans"><p>** 集体诉讼期间：**2023 年 6 月 5 日至 2025 年 12 月 26 日</p>
</div><p><strong>DEADLINE:</strong> April 6, 2026</p>
<div class="lb-trans"><p>** 截止日期：**2026 年 4 月 6 日</p>
</div><p><strong>CASE DETAILS:</strong> According to the Complaint, the Company made false and misleading statements to the market. Mereo misled investors about its Phase 3 ORBIT and COSMIC programs. Both programs failed to achieve their endpoints against placebo or bisphosphonate control groups, respectively. Based on these facts, Mereo's public statements were false and materially misleading throughout the class period.</p>
<div class="lb-trans"><p><strong>案件详情：</strong> 根据投诉，公司向市场发布了虚假和误导性声明。Mereo 误导投资者关于其第三阶段 ORBIT 和 COSMIC 项目。这两个项目在对照组中未能达到其终点。基于这些事实，Mereo 在集体诉讼期间的公开声明是虚假且具有实质性误导性的。</p>
</div><p>If you are a shareholder who suffered a loss, contact us to participate.</p>
<div class="lb-trans"><p>如果您是遭受损失的股东，请联系我们以参与。</p>
</div><p><strong>WHY DJS LAW GROUP?</strong> DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.</p>
<div class="lb-trans"><p><strong>为什么选择 DJS 律师事务所？</strong> DJS 律师事务所的主要关注点是通过平衡的咨询和积极的倡导来提高投资者回报。我们专注于证券集体诉讼、公司治理诉讼以及国内/国际并购评估。我们的客户是全球一些最大和最复杂的对冲基金和另类资产管理公司。我们客户的诉讼索赔是极其有价值的资产，值得尊重、关注和结果。</p>
</div><p>Join the case to recover your losses.</p>
<div class="lb-trans"><p>加入案件以追回您的损失。</p>
</div><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.</p>
<div class="lb-trans"><p>本新闻稿在某些司法管辖区可能被视为律师广告，依据适用法律和伦理规则。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>联系方式：</strong></p>
</div><p>David J. Schwartz</p>
<div class="lb-trans"><p>David J. Schwartz</p>
</div><p>DJS Law Group</p>
<div class="lb-trans"><p>DJS 律师事务所</p>
</div><p>274 White Plains Road, Suite 1</p>
<div class="lb-trans"><p>274 White Plains Road, Suite 1</p>
</div><p>Eastchester, NY 10709</p>
<div class="lb-trans"><p>Eastchester, NY 10709</p>
</div><p>Phone: 914-206-9742</p>
<div class="lb-trans"><p>电话：914-206-9742</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>电子邮件：[email protected]</p>
</div><p>SOURCE DJS Law Group LLP</p>
<div class="lb-trans"><p>来源 DJS 律师事务所 LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMzEyJk5ld3NJdGVtSWQ9TEEwODY3MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAzMTIwNDE5UFJfTkVXU19VU1BSX19fX19MQTA4Njcx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA08671&amp;Transmission_Id=202603120419PR_NEWS_USPR_____LA08671&amp;DateId=20260312"/></p>

Mereo BioPharma Group plc 因违反证券法被起诉 - 请联系 DJS 律师事务所以讨论您的权利 - MREO